@article{vanOorschotBeckmannSchulzeetal.2011,
  author    = {van Oorschot, Birgitt and Beckmann, Gabriele and Schulze, Wolfgang and Rades, Dirk and Feyer, Petra},
  title     = {Radiotherapeutic options for symptom control in breast cancer},
  series = {Breast Care},
  volume    = {6},
  journal   = {Breast Care},
  number    = {1},
  issn      = {1661-3791},
  doi       = {10.1159/000324564},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-199105},
  pages     = {14-19},
  year      = {2011},
  abstract  = {The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50\% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.},
  language  = {en}
}
@article{vanOorschotRadesLordick2013,
  author    = {van Oorschot, Birgitt and Rades, Dirk and Lordick, Florian},
  title     = {Connections Are Clearly More Complex},
  series = {Deutsches {\"A}rzteblatt international},
  volume    = {110},
  journal   = {Deutsches {\"A}rzteblatt international},
  number    = {44},
  doi       = {10.3238/arztebl.2013.0753a},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-128837},
  pages     = {753},
  year      = {2013},
  abstract  = {No abstract available.},
  language  = {en}
}
@article{BolmZemskovZelleretal.2022,
  author    = {Bolm, Louisa and Zemskov, Sergii and Zeller, Maria and Baba, Taisuke and Roldan, Jorge and Harrison, Jon M. and Petruch, Natalie and Sato, Hiroki and Petrova, Ekaterina and Lapshyn, Hryhoriy and Braun, Ruediger and Honselmann, Kim C. and Hummel, Richard and Dronov, Oleksii and Kirichenko, Alexander V. and Klinkhammer-Schalke, Monika and Kleihues-van Tol, Kees and Zeissig, Sylke R. and Rades, Dirk and Keck, Tobias and Fernandez-del Castillo, Carlos and Wellner, Ulrich F. and Wegner, Rodney E.},
  title     = {Concepts and outcomes of perioperative therapy in stage IA-III pancreatic cancer — a cross-validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT)},
  series = {Cancers},
  volume    = {14},
  journal   = {Cancers},
  number    = {4},
  issn      = {2072-6694},
  doi       = {10.3390/cancers14040868},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-262174},
  year      = {2022},
  abstract  = {(1) Background: The aim of this study is to assess perioperative therapy in stage IA-III pancreatic cancer cross-validating the German Cancer Registry Group of the Society of German Tumor Centers — Network for Care, Quality, and Research in Oncology, Berlin (GCRG/ADT) and the National Cancer Database (NCDB). (2) Methods: Patients with clinical stage IA-III PDAC undergoing surgery alone (OP), neoadjuvant therapy (TX) + surgery (neo + OP), surgery+adjuvantTX (OP + adj) and neoadjuvantTX + surgery + adjuvantTX (neo + OP + adj) were identified. Baseline characteristics, histopathological parameters, and overall survival (OS) were evaluated. (3) Results: 1392 patients from the GCRG/ADT and 29,081 patients from the NCDB were included. Patient selection and strategies of perioperative therapy remained consistent across the registries for stage IA-III pancreatic cancer. Combined neo + OP + adj was associated with prolonged OS as compared to neo + OP alone (17.8 m vs. 21.3 m, p = 0.012) across all stages in the GCRG/ADT registry. Similarly, OS with neo + OP + adj was improved as compared to neo + OP in the NCDB registry (26.4 m vs. 35.4 m, p < 0.001). (4) Conclusion: The cross-validation study demonstrated similar concepts and patient selection criteria of perioperative therapy across clinical stages of PDAC. Neoadjuvant therapy combined with adjuvant therapy is associated with improved overall survival as compared to either therapy alone.},
  language  = {en}
}